Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging

J Ouyang, A Xie, J Zhou, R Liu, L Wang, H Liu… - Chemical Society …, 2022 - pubs.rsc.org
Traditional treatments such as chemotherapy and surgery usually cause severe side effects
and excruciating pain. The emergence of nanomedicines and minimally invasive therapies …

Conductive and semiconductive nanocomposite‐based hydrogels for cardiac tissue engineering

SG Alamdari, A Alibakhshi… - Advanced …, 2022 - Wiley Online Library
Cardiovascular disease is the leading cause of death worldwide and the most common
cause is myocardial infarction. Therefore, appropriate approaches should be used to repair …

Nanomaterials responsive to endogenous biomarkers for cardiovascular disease theranostics

C Wei, Z Jiang, C Li, P Li, Q Fu - Advanced Functional Materials, 2023 - Wiley Online Library
Cardiovascular disease (CVD) is the number one cause of death worldwide, which propels
the development of advanced technologies for CVD diagnosis and treatment. Biomarker …

Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury

J Wang, Y Liu, Y Liu, H Huang, S Roy, Z Song… - Journal of Controlled …, 2023 - Elsevier
Myocardial ischemia-reperfusion injury (IRI) is becoming a typical cardiovascular disease
with increasing worldwide incidence. It is usually induced by the restoration of normal blood …

Nanomaterials as promising theranostic tools in nanomedicine and their applications in clinical disease diagnosis and treatment

W Zhu, Z Wei, C Han, X Weng - Nanomaterials, 2021 - mdpi.com
In recent decades, with the rapid development of nanotechnology, nanomaterials have been
widely used in the medical field, showing great potential due to their unique physical and …

Nanobased platform advances in cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering

L Shariati, Y Esmaeili, I Rahimmanesh… - Environmental …, 2023 - Elsevier
Cardiovascular diseases (CVDs) present a significant threat to health, with traditional
pharmaceuticals for their treatment being hindered by inefficiencies due to non-targeted …

Nanomaterials for detection of biomolecules and delivering therapeutic agents in theragnosis: A review

G Paramasivam, A Sanmugam, VV Palem… - International Journal of …, 2024 - Elsevier
Nanomaterials are emerging facts used to deliver therapeutic agents in living systems.
Nanotechnology is used as a compliment by implementing different kinds of …

Nanodiagnosis and nanotreatment of cardiovascular diseases: An overview

F Sabir, M Barani, M Mukhtar, A Rahdar, M Cucchiarini… - Chemosensors, 2021 - mdpi.com
Cardiovascular diseases (CVDs) are the world's leading cause of mortality and represent a
large contributor to the costs of medical care. Although tremendous progress has been …

Recent trends of contrast agents in ultrasound imaging: a review of the classifications and applications

A Tarighatnia, MR Fouladi, ND Nader… - Materials …, 2022 - pubs.rsc.org
Ultrasound (US) imaging, due to its capabilities of real-time imaging, portability, low cost and
favorable safety, is frequently used as a diagnostic modality for the visualization of different …

[HTML][HTML] Theranostic nanoparticles for the management of thrombosis

P Russell, CE Hagemeyer, L Esser, NH Voelcker - Theranostics, 2022 - ncbi.nlm.nih.gov
Acute thrombosis and thromboembolisms are one of the leading causes of mortality and
morbidity in both developed and developing countries, placing a huge burden on health and …